Índice cintura talla un marcador de obesidad visceral relacionado a cistitis no complicada / Index Waist Size A Visceral Obesity Marker Related To Non-Complicated Cystitis

Objetivo: Determinar la relación entre el índice cintura-talla y la presencia de cistitis no complicada en los pacientes de consulta externa en un centro de atención primaria de Lima en el año 2018. Métodos: Se realizó un diseño observacional analítico, tipo casos y controles. Con una muestra de 131 casos y 131 controles, por muestreo aleatorio simple, sometidos a criterios de selección. Se revisó historias clínicas para la obtención retrospectiva de los datos. Se calculó el Odds Ratio como medida de asociación. Resultados: La media del índice cintura talla para cistitis no complicada fue de 61,91 ± 6.39 para los casos y 58.12 ± 3.87 para los controles. Se encontró asociación estadísticamente significativa entre la presencia de cistitis y el índice- cintura talla (OR 5,27; IC95% 3,10 ­ 8,95; p <0,001). Asimismo, se encontró asociación con el perímetro abdominal (OR 2,11 IC 95% 1,26 ­ 3,55; p=0,005) e IMC (OR 2,02; IC95% 1,20 ­ 3,37; p=0,007). Conclusión: El índice cintura talla tuvo una fuerte asociación con la presencia de cistitis no complicada. Se sugieren estudios prospectivos para corroborar la asociación entre marcadores de obesidad visceral y el desarrollo de infección de tracto urinario.

Objective: The aim of this study was to determine the association between waist to height ratio and uncomplicated cystitis in a primary health care center in Lima, during the year 2018. Methods: We conducted an observational, analytical, case-control study, in which a total of 131 cases and 131 controls were obtained by simple random sample, applying exclusion and inclusion criteria. Retrospective recollection of the data was performed using the medical record of each selected patient. Odds ratio was calculated to measure the strength of association. Results: the waist to height ratio mean for uncomplicated cystitis was 61,9 ± 6.39 and 58.12 ± 3.87 for the controls. We found an statistical significant association between uncomplicated cystitis and waist to height ratio (OR 5,27; 95%CI 3,10 ­ 8,95; p <0,001). Waist circumference (OR 2,11 95%CI;1,26 ­ 3,55; p=0,005) and body mass index (OR 2,02; 95%CI 1,20 ­ 3,37; p=0,007) were also associated. Conclusion: we found a strong association between waist to height ratio and uncomplicated cystitis, prospective studies are suggested to confirm the association between visceral obesity and the appearance of urinary tract infections

Efficacy of Cefcapene Pivoxil for Empirical Therapy of Acute Uncomplicated Cystitis / 감염과화학요법

BACKGROUND: A high prevalence of fluoroquinolone resistance among uropathogens has been observed in Korea. Since empirical antimicrobial therapy should be guided by the proportion of pathogens resistant to the chosen antibiotic, the limitation of fluoroquinolones as the first empirical choice for acute cystitis is noticed in the clinical setting. The present study was undertaken to determine the susceptibility profiles of urinary isolates to cefcapene pivoxil and assess the clinical efficacy in patients with acute uncomplicated cystitis. MATERIALS AND METHODS: The study was a prospective, open label, non-comparative, non-blinded trial. Ninety-two patients with acute, uncomplicated symptomatic cystitis from two hospitals were treated with cefcapene pivoxil 100 mg tid for 5 days and followed up for 2 weeks. RESULTS: Seventy-seven of the 92 patients were evaluated. Bacteriological eradication of initial pathogens was achieved in 97.4% by 2 weeks after therapy termination. Seventy-four of 77 (96.1%) patients were symptomatically cured or improved after completion of therapy. Drug related adverse experiences were seen in 8 patients. None necessitated cessation of therapy. No significant biochemical or hematological abnormalities occurred. CONCLUSION: These results demonstrate the clinical efficacy and safety of empirical 5-day cefcapene pivoxil for acute uncomplicated cystitis.

Efficacy of Cefcapene Pivoxil for Empirical Therapy of Acute Uncomplicated Cystitis / 감염과화학요법

BACKGROUND: A high prevalence of fluoroquinolone resistance among uropathogens has been observed in Korea. Since empirical antimicrobial therapy should be guided by the proportion of pathogens resistant to the chosen antibiotic, the limitation of fluoroquinolones as the first empirical choice for acute cystitis is noticed in the clinical setting. The present study was undertaken to determine the susceptibility profiles of urinary isolates to cefcapene pivoxil and assess the clinical efficacy in patients with acute uncomplicated cystitis. MATERIALS AND METHODS: The study was a prospective, open label, non-comparative, non-blinded trial. Ninety-two patients with acute, uncomplicated symptomatic cystitis from two hospitals were treated with cefcapene pivoxil 100 mg tid for 5 days and followed up for 2 weeks. RESULTS: Seventy-seven of the 92 patients were evaluated. Bacteriological eradication of initial pathogens was achieved in 97.4% by 2 weeks after therapy termination. Seventy-four of 77 (96.1%) patients were symptomatically cured or improved after completion of therapy. Drug related adverse experiences were seen in 8 patients. None necessitated cessation of therapy. No significant biochemical or hematological abnormalities occurred. CONCLUSION: These results demonstrate the clinical efficacy and safety of empirical 5-day cefcapene pivoxil for acute uncomplicated cystitis.